Dear sandy
here is the details I recived from baxter Oncology
Dear Mrs. Ward,
Thank you for contacting Baxter Oncology.
Miltex is a topical treatment for skin mets deriving from breast cancer. I
t is marketed in a number of countries but it is not approved in Australia.
Of course we would like to support you to get the product to treat your
skin lesions and hopefully you will benefit from the use of Miltex as other
patients do.
I see three potential ways to obtain the product:
1. To obtain the product via an international pharmacy (e.g. from France,
Germany, Italy, Spain where the product is approved). Here we can provide
you with contact details if needed.
2. To check with our local Medical Director for Australia - Dr. Barry Dale
- about possible local opportunities to get Miltex in Australia (I have Dr.
Dale copied in this e-mail and by that you have his e-mail contact as
well).
3. To check with our global Medical team (Drs. Gimonet and Martinez) -
about specifics programs they might propose you to participate if there are
any (I have Dr. Gimonet and Dr. Martinez copied in this e-mail and by that
you have their e-mail contacts as well).
With my very best regards.
Dr. Udo Müller
_________________________________________________
Udo W. Müller M.D.
Director Medical Marketing Europe, Middle East and Africa
Baxter Deutschland GmbH
Im Breispiel 13, D - 69126 Heidelberg
Home Office: Müllheimer Strasse 20, D - 79292 Pfaffenweiler
Phone Baxter Office: +49-6221-397-346, Tie Line 243-346
Phone Home Office: +49-7664-611-161
Fax Home Office: +49-7664-611495
Mobile Phone: +49-172-3862-610
E-mail to:
udo_mueller@baxter.com
The information transmitted is intended only for the person(s)or